Loading menu...
Prostate cancer is the second leading cause of cancer deaths among US men  Over 200,000 new patients are diagnosed with prostate cancer every year in the US alone  About 35,000 of these men have advanced metatstatic prostate tumor for whom there is no cure 

Hasan Mukhtar, PhD

Scientific Advisory Board Member

Dr. Mukhtar is the Helfaer Professor of Cancer Research and Vice Chair or Research, Department of Dermatology, UW-Madison and Chairman, Department Of Defense Prostate Cancer Medical Research Program (US Army DOD PCMRP) Panel.

Dr. Mukhtar is also the Associate Editor of the International Journal of Oncology, Clinical Cancer Research, and Cancer Therapy. Dr. Mukhtar is an expert in anti-oxidant natural products and among the first pioneers in biochemically identifying and elucidating the mechanisms and therapeutic uses of Green Tea Polyphenols and other therapeutics, including CPC-300.

He has pioneered these and other important new multi-targeted natural products as highly active pharmaceutical drugs for the therapy and prevention of prostate adenocarcinomas, pancreatic adenocarcinomas, skin and breast carcinomas.

Dr. Mukhtar's research focus is cancer prevention and therapy and to establish the utility of naturally occurring dietary chemical substances in therapy of prostate and skin cancers. For these studies, Dr. Mukhtar has used cellular and molecular approaches in cell culture systems and intervention studies in transgenic mouse models. Dr. Muhktar is establishing a mechanistic basis for developing novel approaches for prevention and therapy of skin, pancreas and prostate cancers.